Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Biotech
Sionna’s cystic fibrosis flop a ‘significant’ boost for Vertex
Sionna said it plans to “take actions to preserve capital while evaluating next steps.”
Nick Paul Taylor
Aug 10, 2026 9:38am
Vertex’s latest autoimmune TCE play involves $28M to AbCellera
Jul 29, 2026 8:20am
Eli Lilly takes top spot on new biopharma productivity ranking
Jul 28, 2026 1:00pm
Fierce Pharma
Vertex to pay $10B for Crinetics in its largest-ever deal
Jul 7, 2026 8:08am
Vertex drops Moderna-partnered inhaled CF candidate
May 4, 2026 5:48pm
AbbVie inks $745M deal with China’s Haisco for two pain assets
Apr 13, 2026 9:48am
